Floris van Delft

Floris van Delft

Company: Synaffix

Job title: Chief Scientific Officer

Seminars:

Extension of toxSYN Platform with Best-in-Class Linker-Payloads Based on Validated Topiosomerase 1 Inhibitor (Exatecan) & DNA-damaging Agent (Calicheamicin) 10:00 am

SYNtecan E™ and SYNeamicin G™ linker-payloads show excellent in vivo efficacy and tolerability Immunogenic cell-death driven by SYNtecan E™ ADCs corroborated in syngeneic mouse models Comprehensive set of linker-payloads enables matching of payload MOA to any clinical indicationRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.